Affimed Operating Income vs Cost Of Revenue Analysis

AFMD Stock

USD 2.84 0.03 1.05%

Affimed NV financial indicator trend analysis is way more than just evaluating Affimed NV prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Affimed NV is a good investment. Please check the relationship between Affimed NV Operating Income and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.

Operating Income vs Cost Of Revenue

Operating Income vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Affimed NV Operating Income account and Cost Of Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Affimed NV's Operating Income and Cost Of Revenue is -0.7. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Affimed NV, assuming nothing else is changed. The correlation between historical values of Affimed NV's Operating Income and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Affimed NV are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Operating Income i.e., Affimed NV's Operating Income and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.7

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Affimed NV operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Affimed NV is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Affimed NV income statement and represents the costs associated with goods and services Affimed NV provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Affimed NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Affimed NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.At present, Affimed NV's Enterprise Value is projected to decrease significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Interest Expense	712K	1.6M	1.8M	1.8M
Depreciation And Amortization	1.4M	2.8M	1.7M	1.8M

Interest Expense Depreciation And Amortization

Affimed NV fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock
Total Assets		-0.47	0.78	0.9	0.89	0.35	0.37	0.75	-0.93	-0.68	0.88	0.96	0.74	-0.63	1.0	0.61	0.83	0.74	-0.46	0.8	0.77	0.15	0.31	1.0	0.56	0.81
Short Long Term Debt Total	-0.47		-0.32	-0.46	-0.59	-0.32	-0.15	-0.33	0.68	0.36	-0.38	-0.42	-0.27	0.77	-0.48	-0.3	-0.47	-0.29	0.65	-0.37	-0.44	0.3	-0.14	-0.48	-0.05	-0.4
Other Current Liab	0.78	-0.32		0.77	0.64	0.29	0.75	0.52	-0.58	-0.87	0.82	0.6	0.79	-0.44	0.74	0.83	0.89	0.9	-0.3	0.71	0.86	0.23	0.72	0.75	0.46	0.9
Total Current Liabilities	0.9	-0.46	0.77		0.65	0.61	0.33	0.91	-0.82	-0.57	0.76	0.83	0.9	-0.48	0.87	0.56	0.77	0.63	-0.19	0.56	0.68	0.46	0.28	0.87	0.75	0.69
Total Stockholder Equity	0.89	-0.59	0.64	0.65		0.06	0.34	0.5	-0.89	-0.66	0.79	0.86	0.51	-0.84	0.9	0.57	0.77	0.68	-0.8	0.83	0.75	-0.32	0.3	0.9	0.3	0.77
Other Liab	0.35	-0.32	0.29	0.61	0.06		0.08	0.61	-0.34	-0.17	0.24	0.3	0.46	-0.19	0.34	0.05	0.37	0.17	0.25	0.05	0.23	0.61	0.06	0.33	0.28	0.23
Property Plant And Equipment Net	0.37	-0.15	0.75	0.33	0.34	0.08		-0.01	-0.12	-0.9	0.63	0.1	0.42	-0.32	0.32	0.9	0.78	0.87	-0.26	0.56	0.8	0.01	1.0	0.35	-0.02	0.82
Current Deferred Revenue	0.75	-0.33	0.52	0.91	0.5	0.61	-0.01		-0.73	-0.22	0.5	0.77	0.85	-0.37	0.73	0.25	0.5	0.29	-0.08	0.26	0.38	0.49	-0.06	0.72	0.87	0.37
Net Debt	-0.93	0.68	-0.58	-0.82	-0.89	-0.34	-0.12	-0.73		0.48	-0.74	-0.95	-0.6	0.71	-0.94	-0.39	-0.67	-0.53	0.56	-0.71	-0.61	0.0	-0.07	-0.93	-0.49	-0.63
Retained Earnings	-0.68	0.36	-0.87	-0.57	-0.66	-0.17	-0.9	-0.22	0.48		-0.86	-0.46	-0.55	0.54	-0.65	-0.91	-0.94	-0.99	0.45	-0.83	-0.96	0.02	-0.88	-0.67	-0.1	-0.98
Accounts Payable	0.88	-0.38	0.82	0.76	0.79	0.24	0.63	0.5	-0.74	-0.86		0.76	0.67	-0.54	0.85	0.78	0.89	0.89	-0.42	0.93	0.88	0.1	0.58	0.87	0.34	0.91
Cash	0.96	-0.42	0.6	0.83	0.86	0.3	0.1	0.77	-0.95	-0.46	0.76		0.63	-0.56	0.97	0.38	0.65	0.54	-0.41	0.73	0.58	0.14	0.04	0.96	0.58	0.63
Non Current Assets Total	0.74	-0.27	0.79	0.9	0.51	0.46	0.42	0.85	-0.6	-0.55	0.67	0.63		-0.37	0.68	0.6	0.72	0.58	-0.14	0.41	0.63	0.44	0.38	0.69	0.84	0.62
Long Term Debt	-0.63	0.77	-0.44	-0.48	-0.84	-0.19	-0.32	-0.37	0.71	0.54	-0.54	-0.56	-0.37		-0.64	-0.45	-0.67	-0.49	0.9	-0.56	-0.65	0.51	-0.31	-0.64	-0.08	-0.61
Cash And Short Term Investments	1.0	-0.48	0.74	0.87	0.9	0.34	0.32	0.73	-0.94	-0.65	0.85	0.97	0.68	-0.64		0.57	0.8	0.72	-0.48	0.81	0.75	0.12	0.27	1.0	0.52	0.79
Net Receivables	0.61	-0.3	0.83	0.56	0.57	0.05	0.9	0.25	-0.39	-0.91	0.78	0.38	0.6	-0.45	0.57		0.86	0.91	-0.4	0.66	0.9	0.02	0.88	0.59	0.25	0.89
Common Stock Total Equity	0.83	-0.47	0.89	0.77	0.77	0.37	0.78	0.5	-0.67	-0.94	0.89	0.65	0.72	-0.67	0.8	0.86		0.94	-0.49	0.81	0.97	0.07	0.75	0.82	0.31	0.98
Common Stock Shares Outstanding	0.74	-0.29	0.9	0.63	0.68	0.17	0.87	0.29	-0.53	-0.99	0.89	0.54	0.58	-0.49	0.72	0.91	0.94		-0.39	0.86	0.96	0.07	0.84	0.73	0.18	0.99
Non Current Liabilities Total	-0.46	0.65	-0.3	-0.19	-0.8	0.25	-0.26	-0.08	0.56	0.45	-0.42	-0.41	-0.14	0.9	-0.48	-0.4	-0.49	-0.39		-0.54	-0.53	0.78	-0.25	-0.48	0.07	-0.49
Inventory	0.8	-0.37	0.71	0.56	0.83	0.05	0.56	0.26	-0.71	-0.83	0.93	0.73	0.41	-0.56	0.81	0.66	0.81	0.86	-0.54		0.83	-0.13	0.52	0.82	0.09	0.88
Other Stockholder Equity	0.77	-0.44	0.86	0.68	0.75	0.23	0.8	0.38	-0.61	-0.96	0.88	0.58	0.63	-0.65	0.75	0.9	0.97	0.96	-0.53	0.83		-0.02	0.77	0.76	0.23	0.97
Total Liab	0.15	0.3	0.23	0.46	-0.32	0.61	0.01	0.49	0.0	0.02	0.1	0.14	0.44	0.51	0.12	0.02	0.07	0.07	0.78	-0.13	-0.02		-0.01	0.11	0.52	0.01
Property Plant And Equipment Gross	0.31	-0.14	0.72	0.28	0.3	0.06	1.0	-0.06	-0.07	-0.88	0.58	0.04	0.38	-0.31	0.27	0.88	0.75	0.84	-0.25	0.52	0.77	-0.01		0.29	-0.07	0.79
Total Current Assets	1.0	-0.48	0.75	0.87	0.9	0.33	0.35	0.72	-0.93	-0.67	0.87	0.96	0.69	-0.64	1.0	0.59	0.82	0.73	-0.48	0.82	0.76	0.11	0.29		0.51	0.8
Intangible Assets	0.56	-0.05	0.46	0.75	0.3	0.28	-0.02	0.87	-0.49	-0.1	0.34	0.58	0.84	-0.08	0.52	0.25	0.31	0.18	0.07	0.09	0.23	0.52	-0.07	0.51		0.22
Common Stock	0.81	-0.4	0.9	0.69	0.77	0.23	0.82	0.37	-0.63	-0.98	0.91	0.63	0.62	-0.61	0.79	0.89	0.98	0.99	-0.49	0.88	0.97	0.01	0.79	0.8	0.22

Click cells to compare fundamentals

Affimed NV Account Relationship Matchups

Affimed NV fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	112.4M	175.7M	225.1M	200.5M	97.2M	105.8M
Short Long Term Debt Total	3.2M	1.3M	18.7M	18.2M	19.4M	11.4M
Other Current Liab	24.3M	517K	58.5M	46.2M	53.1M	55.8M
Total Current Liabilities	35.2M	67.0M	64.5M	34.7M	25.9M	28.4M
Total Stockholder Equity	38.7M	72.0M	136.0M	152.9M	57.8M	45.3M
Other Liab	37.5M	38.0M	36.0M	7.2M	8.3M	15.7M
Property Plant And Equipment Net	3.1M	3.2M	4.8M	4.4M	12.9M	13.6M
Current Deferred Revenue	21.4M	55.0M	44.4M	9.2M	619K	588.1K
Net Debt	(92.0M)	(145.6M)	(178.9M)	(172.1M)	(19.2M)	(20.1M)
Retained Earnings	(234.5M)	(275.9M)	(333.4M)	(430.2M)	(536.1M)	(509.3M)
Accounts Payable	10.7M	11.4M	18.9M	19.1M	18.9M	10.3M
Cash	95.2M	146.9M	197.6M	190.3M	38.5M	36.6M
Non Current Assets Total	6.4M	24.9M	18.7M	4.4M	13.0M	7.3M
Long Term Debt	278K	231K	17.1M	11.7M	6.3M	6.0M
Cash And Short Term Investments	104.1M	146.9M	197.6M	190.3M	72.9M	94.5M
Net Receivables	1.5M	2.4M	4.8M	2.7M	5.3M	5.6M
Common Stock Total Equity	468K	624K	762K	983K	1.1M	1.2M
Common Stock Shares Outstanding	6.4M	8.3M	12.0M	14.2M	14.9M	15.7M
Liabilities And Stockholders Equity	112.4M	175.7M	225.1M	200.5M	97.2M	105.8M
Non Current Liabilities Total	38.5M	36.7M	24.6M	12.9M	13.4M	23.3M
Inventory	296K	246K	421K	628K	463K	315.3K
Other Stockholder Equity	273.2M	346.9M	468.1M	469.3M	539.8M	566.7M
Total Liab	73.7M	103.7M	89.2M	47.6M	39.4M	60.4M
Property Plant And Equipment Gross	3.1M	3.2M	4.8M	4.4M	16.0M	16.8M
Total Current Assets	105.9M	150.8M	206.4M	196.1M	84.2M	98.5M
Accumulated Other Comprehensive Income	272.4M	346.9M	468.1M	581.6M	592.4M	622.1M
Intangible Assets	137K	1.7M	1.6M	58K	25K	23.8K
Common Stock	762K	983K	1.2M	1.5M	1.5M	1.6M
Property Plant Equipment	1.4M	3.1M	3.2M	4.8M	5.5M	5.8M
Net Tangible Assets	40.1M	38.5M	70.3M	134.3M	154.5M	162.2M
Short Long Term Debt	2.1M	92K	580K	5.9M	5.8M	8.3M
Short Term Debt	2.6M	584K	1.3M	6.3M	6.4M	3.4M
Capital Lease Obligations	804K	974K	1.1M	572K	7.2M	7.6M
Other Current Assets	8.9M	1.3M	3.5M	(2.7M)	5.5M	5.8M
Net Invested Capital	41.1M	72.3M	153.6M	170.5M	70.0M	92.9M
Net Working Capital	70.7M	83.8M	141.8M	161.4M	58.3M	98.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:

How To Invest In Affimed

Details

Is Affimed Stock a good investment?

Details

What is Affimed NV's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.70)

Revenue Per Share

0.493

Quarterly Revenue Growth

(0.90)

Return On Assets

(0.49)

Return On Equity

(1.24)

The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Affimed Operating Income vs Cost Of Revenue Analysis

Operating Income vs Cost Of Revenue

Operating Income vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Operating Income

Cost Of Revenue

Affimed NV fundamental ratios Correlations

Affimed NV Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Affimed NV fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.98	Common Stock Total Equity

Common Stock Shares Outstanding	- 0.99	Retained Earnings
Common Stock	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.96	Retained Earnings
Cash	- 0.95	Net Debt
Common Stock Total Equity	- 0.94	Retained Earnings
Cash And Short Term Investments	- 0.94	Net Debt